AC220 - CAS# 950769-58-1 Catalog No.:M60435-2S SAG was shown to prevent

SAG was shown to prevent glucocorticoid-induced neonatal cerebellar injury

Smiles: COC1=CC2=C(NCCCCCN3CCCC3)N=C(N=C2C=C1OC)N1CCCC1

8 nM) very similar to that of Chrysamine-G

is a novel glycine antagonist of NMDA receptor activation

BGT226 was used at 0

AC220 - CAS# 950769-58-1 Catalog No.:M60435-2S SAG was shown to preventQuizartinib, also know as AC220 and AC010220, CAS No. 950769 58 1, is an orally available FLT3 STK1 inhibitor with potential antineoplastic activity. Class III receptor tyrosine kinase inhibitor AC220 selectively inhibits class III receptor tyrosine kinases, including FMS related tyrosine kinase 3 (FLT3 STK1), colony stimulating factor 1 receptor (CSF1R FMS), stem cell factor receptor (SCFR KIT), and platelet derived growth factor receptors (PDGFRs),